Medline (Nasdaq:MDLN) posted fourth-quarter results that topped sales expectations but fell short of earnings forecasts.
Medline (MDLN) is back on investor radars after a quiet stretch, with the stock hovering around 29 dollars despite sizable annual revenue and steady profitability that invite a closer look at ...
Medline (Nasdaq:MDLN) today announced an underwritten public offering of 75 million shares of its Class A common stock.
Shares of U.S. medical supplies giant Medline jumped in its debut on the Nasdaq on Wednesday after the biggest initial public offering of the year globally. Shares closed up more than 41% at $41 a ...
The CEO of Northfield-based Medline cheered the company’s successful initial public offering late last year following the company’s first earnings call Wednesday.
・Medline plans to sell 179 million Class A shares at $26 to $30 each. ・Major institutional investors signaled interest in buying as much as $2.35 billion of stock. ・Proceeds will be used to buy units ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results